Search over 87,000 Information Industry Mergers & Acquisitions:
JLL Partners, Water Street Healthcare Partners, acquired THREAD Research
Like THREAD Research
Education

Finance

Healthcare

Consumer

Human Capital

Media & Marketing

Software

Online & Mobile

Managed Services & IT Consulting

Private Equity

Miscellaneous

Online & Mobile
E-Marketing & Search

Communications

SaaS & Cloud

Software
Niche Software

Healthcare
Pharma IT

Search Breadth
Narrower
Broader
By THREAD Research
Healthcare

Software

Online & Mobile

Private Equity

Online & Mobile
Communications

Software
Niche Software

Healthcare
Pharma IT

By JLL Partners
Education

Finance

Healthcare

Consumer

Human Capital

Media & Marketing

Software

Online & Mobile

Managed Services & IT Consulting

Private Equity

Miscellaneous

Human Capital
HR Software

Staffing Services

Online & Mobile
E-Marketing & Search

Communications

SaaS & Cloud

Software
Niche Software

Consumer
Miscellaneous

Marketing

Media & Marketing
Marketing

Healthcare
Pharma IT

Health IT

Medical Education

Pharma Business Services

Healthcare Business Services

Finance
Payments

Education
Higher-Ed Institutions

Professional Training Services

JLL Partners Competitor`s Deals
There are no acquistions that meet the criteria.
Try broadening Search Breadth
Search Breadth
Narrower
Broader
note: a single transaction may fall into multiple segments
view all transactions
All Segments
01/08/04 to 08/11/22
(1005 results)
Transactions
Tombstones
Trends
Highlights
Overview
Geography
Company
Like THREAD Research
- buyer to watch list
- seller to watch list
closed 8/28/2019 via BNC Analysis
JLL Partners, Water Street Healthcare Partners, acquired THREAD Research
synopsis: Water Street Healthcare Partners and JLL Partners have acquired Orange County, California-based THREAD, a provider of technology that enables virtual research approaches to modernize clinical studies and registries.
buyer:
JLL Partners
buyer: Water Street Healthcare Partners
buyer: Water Street Healthcare Partners
JLL Partners is a middle-market private equity firm with a 30-year track record of building and transforming businesses. Water Street is a strategic investor focused exclusively on healthcare. The firm has a strong record of building market-leading companies across key growth sectors in healthcare. "
target:
THREAD Research
THREAD is a virtual research platform used by biopharma, CROs, non-profit researchers, and life science organizations to capture global clinical study data in between, as well as during and instead of clinic visits.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
share
watch
bookmark
-
press release
closed 12/15/2021 via PR Newswire
Veeva Systems, acquired Veracity Logic
synopsis: Veeva Systems, the global leader in cloud software for the life sciences industry, has acquired Veracity Logic, a provider of cloud software for randomization and trial supply management (RTSM). Veracity Logic provides a robust, reliable, and user-friendly RTSM solution designed to simplify complex processes and expedite clinical trials.
buyer:
Veeva Systems
(VEEV:$1,762.04)
Veeva Systems Inc. is the leader in cloud-based software for the global life sciences industry. Committed to innovation, product excellence, and customer success, Veeva serves more than 775 customers, ranging from the world's largest pharmaceutical companies to emerging biotechs. "
target:
Veracity Logic
Veracity Logic is a provider of cloud software for randomization and trial supply management (RTSM). Veracity Logic's RTSM solution simplifies complex processes and expedites clinical trials. Their software covers a range of trial designs in pharma/biotech, medical device, and diagnostics.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
share
watch
bookmark
-
press release
closed 9/1/2021 via BNC Analysis
Instem, acquired PDS Life Sciences
synopsis: Instem, a leading provider of IT solutions and services to the global life sciences market, has acquired PDS Life Sciences, a leading global provider of software and solutions for life sciences research and development. PDS offers SaaS solutions that make it simple for scientists to conduct toxicology, pathology and safety assessment research.
buyer:
Instem
(AIM:INS:$38.90)
Instem is a leading supplier of IT applications to the early development healthcare market delivering compelling solutions for data collection, management and analysis across the R&D continuum. Instem applications are in use by customers worldwide. "
target:
PDS Life Sciences
PDS Life Sciences is a leading global provider of software and solutions for life sciences research and development. PDS offers SaaS solutions that make it simple for scientists to conduct toxicology, pathology and safety assessment research that drives insightful decisions.
price ($mm)
$16
rev ($mm)
$7
EBITDA ($mm)
EV / rev
2.1x
EV / EBITDA
share
watch
bookmark
-
press release
closed 5/30/2021 via BNC Analysis
CSAM Health AS, acquired MedSciNet
synopsis: CSAM Health Group AS, the leading provider of niche eHealth solutions in the Nordics, announced that they have acquired MedSciNet AB, a provider of benchmark eHealth solutions within clinical research.
buyer:
CSAM Health AS
(OB:CSAM:$34.31)
CSAM is a leading Norwegian company in the specialized eHealth market with a unique blend of best in class innovative technology, and outstanding human skills. Their diverse portfolio of software solutions enables healthcare providers to access relevant clinical information at the point of care. "
target:
MedSciNet
MedSciNet is a Stockholm based company specialising in design and development of web applications and on-line database systems for clinical trials and studies, quality registries, medical bio-banks, and other solutions within the medical field.
price ($mm)
$2.88
rev ($mm)
$2
EBITDA ($mm)
EV / rev
1.7x
EV / EBITDA
share
watch
bookmark
-
press release
announced 5/27/2021 via PR Newswire
Thoma Bravo, LLC, will acquire Greenphire, Inc
synopsis: Thoma Bravo, a leading private equity investment firm focused on the software and technology-enabled services sector, has reached an agreement to acquire Greenphire, the global leader in financial lifecycle management software for clinical trials, from The Riverside Company.
buyer:
Thoma Bravo, LLC
target: Greenphire, Inc
Thoma Bravo is a leading private equity firm focused on the software and technology-enabled services sectors. Thoma Bravo partners with a company’s management team to implement operating best practices, invest in growth initiatives and make acquisitions intended to accelerate revenue and earnings. "
target parent:
The Riverside Company
target: Greenphire, Inc
Greenphire is the leader in global clinical trial financial process automation. Greenphire's best-in-class solutions optimize clinical trial performance by streamlining payment and logistical workflows from sponsors and CROs to sites and patients.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
share
watch
bookmark
-
press release
closed 3/1/2021 via BusinessWire
Instem, acquired The Edge Software Consultancy Ltd.
synopsis: Instem, a leading provider of IT solutions and services to the global life sciences market, has acquired The Edge Software Consultancy Ltd., a UK-based software company specializing in the pharmaceutical and biotechnology industry. The Edge focuses on improving the efficiency of drug discovery research and development.
buyer:
Instem
(AIM:INS:$38.90)
Instem is a leading supplier of IT applications to the early development healthcare market delivering compelling solutions for data collection, management and analysis across the R&D continuum. Instem applications are in use by customers worldwide. "
target:
The Edge Software Consultancy Ltd.
The Edge is a UK-based software company specializing in the pharmaceutical and biotechnology industry. The Edge focuses on improving the efficiency of drug discovery research and development. Their BioRails platform enables automated data capture over the entire research and development process.
price ($mm)
$7.88
rev ($mm)
$3
EBITDA ($mm)
EV / rev
3.1x
EV / EBITDA
share
watch
bookmark
-
press release
closed 1/19/2021 via GlobeNewswire
Scarritt Group Inc., acquired TrialTech Medical Inc.
synopsis: Scarritt Group Inc., a technology-enabled leader in the planning and execution of meetings for Investigators and Coordinators of clinical trials, has acquired TrialTech Medical Inc, a leader in the application of cloud- based software and artificial intelligence enabled digital marketing for the recruitment of eligible subjects for clinical trials.
buyer:
Scarritt Group Inc.
Scarritt Group is a technology-enabled, full service meeting planning and logistics company specializing in delivering clinical trial meetings worldwide. "
target:
TrialTech Medical Inc.
TrialTech Medical is a software and services company supporting the pharmaceutical, biotechnology and medical device industries. They work in coordination with their clients' medical and clinical operations teams to optimize the process of clinical trial planning, recruitment and enrollment.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
share
watch
bookmark
-
press release
closed 11/20/2019 via BNC Analysis
Monterro, acquired Viedoc
synopsis: Monterro, the leading B2B software investor in the Nordics, has acquired a majority stake in Viedoc, a modern and sophisticated electronic data capture (EDC) system. Viedoc enables researchers to gather and evaluate clinical trial data more efficiently.
buyer:
Monterro
Sweden-based Monterro is the leading B2B software investor in the Nordics, with a mission to turn software companies into market leaders. With operational experience from successfully developing and running companies, Monterro actively supports its portfolio companies in all aspects of growth. "
target:
Viedoc
Viedoc is a modern and sophisticated electronic data capture (EDC) system. Viedoc enables researchers to gather and evaluate clinical trial data more efficiently. Their powerful EDC system has been used in over 2000 trials in more than 75 countries in all therapeutic areas and clinical phases.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
share
watch
bookmark
-
press release
closed 10/24/2019 via BNC Analysis
TrialScope, acquired Clinical Trial Connect, LLC
synopsis: TrialScope has acquired Clinical Trial Connect, a platform used by disease foundations and advocacy groups that connects their community members to relevant clinical trials. As part of the acquisition, founder Mike Wenger will share his technological expertise as part of the TrialScope team.
buyer:
TrialScope
TrialScope is the global leader in clinical trial transparency and compliance. TrialScope's tools and systems enable their customers to improve their clinical trial process, mitigate registry and lifecycle risk, and ultimately achieve greater business success. "
target:
Clinical Trial Connect, LLC
Clinical Trial Connect is a platform used by disease foundations and advocacy groups that connects their community members to relevant clinical trials. Clinical Trial Connect was founded by Mike Wenger, who developed his own algorithm for matching patients to clinical trials.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
share
watch
bookmark
-
press release
announced 7/17/2019 via GlobeNewswire
Anju Software, will acquire OmniComm Systems, Inc.
synopsis: Anju Software, a leading provider of comprehensive software solutions to the life sciences industry, will be acquiring OmniComm, a healthcare technology company that provides web-based electronic data capture and eClinical solutions and related value-added services.
buyer parent:
ABRY Partners, LLC
buyer: Anju Software
buyer: Anju Software
Anju Software, Inc. is a leading provider of comprehensive software solutions to the life sciences industry that provides an integrated platform spanning clinical operations, medical affairs, and commercial divisions, including integrated data intelligence. "
target:
OmniComm Systems, Inc.
(OTCPK:OMCM:$14,891.70)
OmniComm is a healthcare technology company that provides web-based electronic data capture and eClinical solutions and related value-added services to pharmaceutical and biotech companies, contract research organizations, and other clinical trial sponsors.
price ($mm)[EV]
$72 [$81]
rev ($mm)
$25
EBITDA ($mm)
$2
EV / rev
3.4x
EV / EBITDA
46.2x
share
watch
bookmark
-
press release
announced 6/12/2019 via BusinessWire
Dassault Systemes, will acquire Medidata
synopsis: Dassault Systèmes, a provider of solutions that transform the way products are designed, provided and supported, will be acquiring Medidata, a provider of a platform for clinical development, commercial, and real-world data.
buyer:
Dassault Systemes
(ENXTPA:DSY:$5,318.32)
Based in France, Dassault Systèmes provides clients with virtual universes to imagine sustainable innovations. Its solutions transform the way products are designed, produced, and supported. They foster social innovation, expanding possibilities for the virtual world to improve the real world. "
target:
Medidata
(MDSO:$660.00)
Medidata is leading the digital transformation of life science, with a platform for clinical development, commercial, and real-world data. Powered by artificial intelligence, Medidata helps accelerate value, minimize risk and optimize outcomes.
price ($mm)[EV]
$5,825 [$5,822]
rev ($mm)
$660
EBITDA ($mm)
$81
EV / rev
8.8x
EV / EBITDA
72.2x
share
watch
bookmark
-
press release
closed 4/10/2019 via BNC Analysis
TriNetX, acquired Custodix N.V.
synopsis: TriNetX has acquired Custodix, a Belgian-based provider of clinical trial patient recruitment solutions. TriNetX is a global health research network that has revolutionised clinical research. Custodix is a provider of clinical trial patient recruitment solutions offering a range of solutions for ensuring compliance.
buyer:
TriNetX
TriNetX is the global health research network enabling healthcare organizations, biopharma and CROs to collaborate, enhance trial design, accelerate recruitment and bring new therapies to market faster. "
target:
Custodix N.V.
Custodix is a Belgian provider of clinical trial patient recruitment solutions offering a range of solutions for ensuring compliance with European and US data protection legislation and security best practices.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
share
watch
bookmark
-
press release
announced 10/17/2018 via Company Press Release
Oracle Corporation, will acquire GoBalto
synopsis: Oracle announced that it has entered into an agreement to acquire goBalto, which delivers leading cloud solutions to accelerate clinical trials by streamlining and automating the selection and set up of the best performing clinical research sites to conduct trials.
buyer:
Oracle Corporation
(ORCL:$41,399.00)
Oracle is a computer technology corporation developing and marketing computer hardware systems and enterprise software products. By eliminating complexity and simplifying IT, Oracle enables its customers to accelerate innovation and create added value for their customers. "
target:
GoBalto
goBalto, Inc. is an award winning, venture backed group of industry veterans that creates simple, focused software for the global drug trial industry. Its products offer drug trial sponsors and clinical research organizations the fastest, easiest possible way to start clinical studies on the web.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
share
watch
bookmark
-
press release
closed 3/21/2018 via BusinessWire
Anju Software, acquired Sylogent
synopsis: Anju Software Inc., a life sciences software platform backed by Providence Equity Partners, has acquired Sylogent. Sylogent delivers cloud based state of the art software solutions and business services to the pharmaceutical industry focused specifically on the information required to bring a product to market.
buyer parent:
Providence Equity Partners Inc.
buyer: Anju Software
buyer: Anju Software
Anju Software is a life sciences enterprise software platform focused on delivering exceptional business application solutions. Anju was founded by professionals with deep software domain expertise and a track record of building software platforms through strategic acquisitions and organic growth. "
target:
Sylogent
Sylogent delivers software and business services to the pharmaceutical industry focused specifically on the information required to bring a product to market. They ensure the timely completion of critical information, maximize compliance goals and reduce risk management liability.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
share
watch
bookmark
-
press release
closed 8/9/2017 via Company Press Release
PRA Health Sciences, acquired Parallel 6
synopsis: HCAP Partners, a California-based mezzanine debt and private equity firm, announced that it has exited its investment in Parallel 6, Inc. (“P6”), a mobile clinical (“mClinical”) SaaS platform designed to recruit, enroll, engage and manage patients in clinical trials. P6 was sold to PRA Health Sciences, Inc.
buyer parent:
Kohlberg Kravis Roberts & Co.
buyer: PRA Health Sciences (PRAH:$1,698.48)
target: Parallel 6
buyer: PRA Health Sciences (PRAH:$1,698.48)
PRA Health Sciences, Inc. is one of the world’s leading global CROs by revenue, providing outsourced clinical development services to the biotechnology and pharmaceutical industries. Since 2000, PRA has participated in approximately 3,500 clinical trials worldwide. "
target parent:
HCAP Partners
target: Parallel 6
Parallel 6’s technology digitally enrolls, engages and manages patients using mobile endpoints. Sponsors and clinical research organizations can connect directly with and manage patients anywhere in the world, seamlessly integrating into their daily lives.
price ($mm)
$40
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
share
watch
bookmark
-
press release
closed 11/16/2016 via BNC Analysis
DrugDev, acquired SecureConsent
synopsis: DrugDev has acquired SecureConsent, a developer of mobile e-consent software. SecureConsent replaces the paper methods that have historically been used to secure informed consent from patients participating in drug studies with an e-consent method that uses tablets and other mobile devices.
buyer:
DrugDev
DrugDev streamlines engagement among sponsors, CROs and doctors to advance the common goal of doing more trials. Through the creation of global, standardized processes DrugDev is consistently and efficiently transforming the way drug developers identify, engage and pay investigators. "
target:
SecureConsent
The software products developed by Secure Consent replace the paper methods that have historically been used to secure informed consent from patients participating in drug studies with an e-consent method that uses tablets and other mobile devices.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
share
watch
bookmark
-
press release
closed 1/19/2016 via PR Newswire
BioClinica, Inc., acquired Clinverse, Inc.
synopsis: Bioclinica, Inc., a specialty trials services and technology provider, announced it has acquired Clinverse, Inc. Clinverse automates and manages the entire financial lifecycle of global clinical trials for contract research organizations and pharmaceutical companies. Its suite of products pays clinical trial sites, vendors and their subjects.
buyer:
BioClinica, Inc.
Bioclinica is a specialty services provider that utilizes expertise and technology to create clarity in the clinical trial process. Bioclinica is organized into three business segments to deliver focused service and multifaceted technologies. "
target:
Clinverse, Inc.
Clinverse, Inc. architected the industry's first automated financial management technology solution for clinical trials. Their solution standardizes clinical trial financial management for millions of financial transactions across the globe, including clinical site payments.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
share
watch
bookmark
-
press release
closed 6/17/2015 via PR Web
Aris Global LLC, acquired Medsight Solutions Inc.
synopsis: ArisGlobal®, a leading provider of Cloud solutions to life sciences companies, is pleased to announce that it has acquired Medsight Solutions, including the revolutionary integrated risk management solution, Medsight Sapphire (now known as ArisGlobal agBalance™).
buyer:
Aris Global LLC
For more than 20 years, ArisGlobal has led in the development of innovative software solutions for pharmacovigilance & safety, regulatory affairs, clinical research and medical information. "
target:
Medsight Solutions Inc.
Medsight Solutions Inc. is a life sciences solutions and professional services company with specialties in Clinical trial optimization, Benefit-risk assessment and Compliance monitoring.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
share
watch
bookmark
-
press release
closed 10/3/2014 via PR Newswire
PAREXEL International Corporation, acquired ClinIntel Ltd.
synopsis: PAREXEL International Corporation, a global clinical research organization, announced that the Company has acquired all of the outstanding equity securities of privately-owned ClinIntel, a provider of clinical Randomization and Trial Supply Management (RTSM) services, based in the United Kingdom.
buyer:
PAREXEL International Corporation
(PRXL:$1,939.36)
PAREXEL International Corporation is a leading global bio/pharmaceutical services organization, providing a broad range of knowledge-based contract research, consulting, and medical communications services to the worldwide pharmaceutical, biotechnology and medical device industries. "
target:
ClinIntel Ltd.
Headquartered in the United Kingdom, ClinIntel is a provider of clinical Randomization and Trial Supply Management (RTSM) services. The company was founded in 2009, and works with biopharmaceutical companies and contract research organizations.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
share
watch
bookmark
-
press release
closed 9/24/2014 via PR Newswire
The WIRB-Copernicus Group, acquired ePharmaSolutions, Inc.
synopsis: WIRB-Copernicus Group (WCG), the world's largest provider of regulatory and ethical review services for clinical research, announced that ePharmaSolutions (ePS) has joined its group of companies. ePharmaSolutions is a leading provider of eClinical solutions and technology-enabled services that improve the conduct of clinical trials.
buyer parent:
Arsenal Capital Partners
buyer: The WIRB-Copernicus Group
buyer: The WIRB-Copernicus Group
WIRB-Copernicus Group (WCG) is the world's largest provider of regulatory and ethical solutions for clinical research, including Institutional Review Board (IRB) and Institutional Biosafety Committee (IBC) review. "
target:
ePharmaSolutions, Inc.
ePharmaSolutions is a leading provider of eClinical solutions and specialty clinical services that help improve the way trial sites are selected, trained, activated and managed to exceed enrollment goals.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
share
watch
bookmark
-
press release
Pages:
- buyer to watch list
- seller to watch list
closed 1/19/2022 via PR Newswire
THREAD Research, acquired inVibe Labs, LLC
synopsis: THREAD, a leading technology and service provider enabling electronic clinical outcome assessments (eCOA) and decentralized clinical trials (DCTs), announced that it has acquired inVibe, the leading voice-powered research and insights technology solution for the life sciences and health care industry.
buyer parent:
JLL Partners
buyer: THREAD Research
buyer: THREAD Research
THREAD is the industry-leading decentralized clinical trials technology and service provider, helping biopharma and CROs decentralize clinical research for sites, participants, caregivers, and home health professionals. "
target:
inVibe Labs, LLC
inVibe is the leading voice-powered research and insights technology solution for the life sciences and health care industry. inVibe is a pioneer in the field of voice technology, having developed the first and only research platform designed exclusively for the healthcare industry.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
share
watch
bookmark
-
press release
closed 8/28/2019 via BNC Analysis
JLL Partners, Water Street Healthcare Partners, acquired THREAD Research
synopsis: Water Street Healthcare Partners and JLL Partners have acquired Orange County, California-based THREAD, a provider of technology that enables virtual research approaches to modernize clinical studies and registries.
buyer:
JLL Partners
buyer: Water Street Healthcare Partners
buyer: Water Street Healthcare Partners
JLL Partners is a middle-market private equity firm with a 30-year track record of building and transforming businesses. Water Street is a strategic investor focused exclusively on healthcare. The firm has a strong record of building market-leading companies across key growth sectors in healthcare. "
target:
THREAD Research
THREAD is a virtual research platform used by biopharma, CROs, non-profit researchers, and life science organizations to capture global clinical study data in between, as well as during and instead of clinic visits.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
share
watch
bookmark
-
press release
- buyer to watch list
- seller to watch list
closed 1/19/2022 via PR Newswire
THREAD Research, acquired inVibe Labs, LLC
synopsis: THREAD, a leading technology and service provider enabling electronic clinical outcome assessments (eCOA) and decentralized clinical trials (DCTs), announced that it has acquired inVibe, the leading voice-powered research and insights technology solution for the life sciences and health care industry.
buyer parent:
JLL Partners
buyer: THREAD Research
buyer: THREAD Research
THREAD is the industry-leading decentralized clinical trials technology and service provider, helping biopharma and CROs decentralize clinical research for sites, participants, caregivers, and home health professionals. "
target:
inVibe Labs, LLC
inVibe is the leading voice-powered research and insights technology solution for the life sciences and health care industry. inVibe is a pioneer in the field of voice technology, having developed the first and only research platform designed exclusively for the healthcare industry.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
share
watch
bookmark
-
press release
closed 4/28/2021 via GlobeNewswire
Xact Data Discovery, acquired Paralaw UK Limited
synopsis: Xact Data Discovery (XDD), a leading international provider of eDiscovery, data management and managed review services for law firms and corporations, acquired Paralaw, a UK-based legal outsourcing company providing managed review staffing, eDiscovery and contracts management services to law firms and corporations.
buyer parent:
JLL Partners
buyer: Xact Data Discovery
buyer: Xact Data Discovery
Xact Data Discovery (XDD) is a leading international provider of eDiscovery, data management and managed review services for law firms and corporations. XDD helps clients optimize their eDiscovery matters by orchestrating precision communication between people, processes, technology and data. "
target:
Paralaw UK Limited
Paralaw is a UK-based legal outsourcing company providing managed review staffing, eDiscovery and contracts management services to law firms and corporations.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
share
watch
bookmark
-
press release
closed 4/20/2021 via GlobeNewswire
Xact Data Discovery, acquired Lexolution LLC
synopsis: Xact Data Discovery (XDD), a leading international provider of eDiscovery, data management and managed review services for law firms and corporations, announced the acquisition of Lexolution, a legal staffing and managed review services company headquartered in New York, NY.
buyer parent:
JLL Partners
buyer: Xact Data Discovery
buyer: Xact Data Discovery
Xact Data Discovery (XDD) is a leading international provider of eDiscovery, data management and managed review services for law firms and corporations. XDD helps clients optimize their eDiscovery matters by orchestrating precision communication between people, processes, technology and data. "
target:
Lexolution LLC
Lexolution is a leading provider of temporary contract attorney staffing and managed review services for law firms and corporations.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
share
watch
bookmark
-
press release
announced 4/20/2021 via GlobeNewswire
Xact Data Discovery will be merged with Consilio,
synopsis: Consilio, a global leader in eDiscovery, document review, risk management, and legal consulting services, and Xact Data Discovery (XDD), a leading international provider of eDiscovery, data management, and managed review services, have agreed to a merger of the two companies.
buyer parent:
GI Partners
buyer: Consilio
target: Xact Data Discovery
buyer: Consilio
Consilio is a global leader in eDiscovery, document review and legal consulting services. Consilio supports multinational law firms and corporations using innovative software, cost-effective managed services and deep legal and regulatory industry expertise. "
target parent:
JLL Partners
target: Xact Data Discovery
Xact Data Discovery (XDD) is a leading international provider of eDiscovery, data management and managed review services for law firms and corporations. XDD helps clients optimize their eDiscovery matters by orchestrating precision communication between people, processes, technology and data.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
share
watch
bookmark
-
press release
closed 4/13/2021 via GlobeNewswire
Xact Data Discovery, purchased eDiscovery Business from Zeledon-Castillo, LLC
synopsis: Xact Data Discovery (XDD) announced the acquisition of Zeledon-Castillo, LLC’s eDiscovery assets. Based in San Antonio, TX, Zeledon-Castillo provides core eDiscovery services to key clients, including a Fortune 500 financial services company, in the southern Texas region. They also offer services for professional graphic design and printing.
buyer parent:
JLL Partners
buyer: Xact Data Discovery
buyer: Xact Data Discovery
Xact Data Discovery (XDD) is a leading international provider of eDiscovery, data management and managed review services for law firms and corporations. XDD helps clients optimize their eDiscovery matters by orchestrating precision communication between people, processes, technology and data. "
seller:
Zeledon-Castillo, LLC
Based in San Antonio, TX, Zeledon-Castillo provides core eDiscovery services to key clients, including a Fortune 500 financial services company, in the southern Texas region. They also offer services for professional graphic design and printing.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
share
watch
bookmark
-
press release
closed 10/14/2020 via PR Newswire
JLL Partners, acquired MedeAnalytics
synopsis: JLL Partners, a New York-based private equity firm, announced that it has acquired MedeAnalytics, a cloud-based enterprise analytics solutions provider for health systems and health plans. MedeAnalytics provides a SaaS-based enterprise healthcare analytics platform with scalable, purpose-built analytics products for payers and providers.
buyer:
JLL Partners
target: MedeAnalytics
JLL Partners is a middle market private equity firm with over three decades of experience transforming businesses in the healthcare, specialty industrials, and business services sectors. The firm is dedicated to partnering with companies that it can help build into market leaders. "
target parent:
Thoma Bravo, LLC
target: MedeAnalytics
A leader in healthcare analytics, MedeAnalytics helps organizations make even smarter decisions. With the most advanced data orchestration in healthcare, their intelligent cloud-based analytics platform combines data to deliver state-of-the-art analytics, all in a business context.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
share
watch
bookmark
-
press release
closed 8/5/2020 via GlobeNewswire
Xact Data Discovery, acquired Anexsys Group Limited
synopsis: Xact Data Discovery (XDD), a leading international provider of eDiscovery, data management and managed review services for law firms and corporations, has acquired Anexsys Group Limited, an eDiscovery services company based in the UK. Adding Anexsys to the XDD family enables XDD to expand eDiscovery, Forensics and Managed Review services in the UK.
buyer parent:
JLL Partners
buyer: Xact Data Discovery
target: Anexsys Group Limited
buyer: Xact Data Discovery
Xact Data Discovery (XDD) is a leading international provider of eDiscovery, data management and managed review services for law firms and corporations. XDD helps clients optimize their eDiscovery matters by orchestrating precision communication between people, processes, technology and data. "
target parent:
Hobs Group
target: Anexsys Group Limited
UK-based Anexsys is a legal technology services consultancy, providing eDiscovery, digital forensics, and hardcopy services to law firms, corporations, and government bodies throughout the UK and Europe. Anexsys designs and implements bespoke software solutions to enhance legal processes.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
share
watch
bookmark
-
press release
closed 7/14/2020 via GlobeNewswire
Xact Data Discovery, acquired LightSpeed Legal
synopsis: Xact Data Discovery (XDD), a leading international provider of eDiscovery, data management and managed review services for law firms and corporations, has acquired LightSpeed Legal, an eDiscovery services company. The acquisition of LightSpeed further bolsters XDD's physical presence in the DC market.
buyer parent:
JLL Partners
buyer: Xact Data Discovery
buyer: Xact Data Discovery
Xact Data Discovery (XDD) is a leading international provider of eDiscovery, data management and managed review services for law firms and corporations. XDD helps clients optimize their eDiscovery matters by orchestrating precision communication between people, processes, technology and data. "
target:
LightSpeed Legal
LightSpeed is an eDiscovery partner that provides leading law firms and corporations with high quality, and defensible strategic solutions. LightSpeed has worked with eDiscovery consulting and digital forensics for over 15 years and has experience in multiple cross-border internal investigations.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
share
watch
bookmark
-
press release
closed 9/4/2019 via GlobeNewswire
Xact Data Discovery, acquired Beyond IT
synopsis: Xact Data Discovery (XDD), a leading international provider of eDiscovery, data management and managed review services for law firms and corporations, announced the acquisition of Beyond IT, a cybersecurity and digital forensics company based in Houshttps://cmdm.berkerynoyes.com/acquisition/Edit/71420#tab_targetton, TX.
buyer parent:
JLL Partners
buyer: Xact Data Discovery
buyer: Xact Data Discovery
Xact Data Discovery (XDD) is a leading international provider of eDiscovery, data management, and managed review services for law firms and corporations. XDD helps clients optimize their eDiscovery matters by orchestrating pristine communication between people, processes, technology, and data. "
target:
Beyond IT
Beyond IT is a licensed and full service Investigations Company providing Computer Forensics, eDiscovery, Network Intrusion, Data Recovery, and Mobile Device Forensics.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
share
watch
bookmark
-
press release
closed 8/28/2019 via BNC Analysis
JLL Partners, Water Street Healthcare Partners, acquired THREAD Research
synopsis: Water Street Healthcare Partners and JLL Partners have acquired Orange County, California-based THREAD, a provider of technology that enables virtual research approaches to modernize clinical studies and registries.
buyer:
JLL Partners
buyer: Water Street Healthcare Partners
buyer: Water Street Healthcare Partners
JLL Partners is a middle-market private equity firm with a 30-year track record of building and transforming businesses. Water Street is a strategic investor focused exclusively on healthcare. The firm has a strong record of building market-leading companies across key growth sectors in healthcare. "
target:
THREAD Research
THREAD is a virtual research platform used by biopharma, CROs, non-profit researchers, and life science organizations to capture global clinical study data in between, as well as during and instead of clinic visits.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
share
watch
bookmark
-
press release
closed 7/2/2019 via GlobeNewswire
Xact Data Discovery, acquired QDiscovery
synopsis: Xact Data Discovery (XDD), a leading international provider of eDiscovery, data management, and managed review services for law firms and corporations, has acquired QDiscovery, an eDiscovery, and digital forensic services provider. QDiscovery provides eDiscovery, forensics, managed review, and consulting services to law firms and corporations.
buyer parent:
JLL Partners
buyer: Xact Data Discovery
buyer: Xact Data Discovery
Xact Data Discovery (XDD) is a leading international provider of eDiscovery, data management, and managed review services for law firms and corporations. XDD helps clients optimize their eDiscovery matters by orchestrating pristine communication between people, processes, technology, and data. "
target:
QDiscovery
QDiscovery is a premier provider of electronic discovery and digital forensic services across the entire Electronic Discovery Reference Model spectrum. Their team serves corporations, law firms, and government enterprises, helping them manage complex matters and reduce the expense of litigation.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
share
watch
bookmark
-
press release
closed 2/12/2019 via GlobeNewswire
Xact Data Discovery, acquired QUiVX
synopsis: Xact Data Discovery (XDD), a leading international provider of eDiscovery, data management and managed review services for law firms and corporations, announced the acquisition of QUiVX’s forensics, review and eDiscovery services.
buyer parent:
JLL Partners
buyer: Xact Data Discovery
buyer: Xact Data Discovery
Xact Data Discovery (XDD) is a leading international provider of eDiscovery, data management and managed review services for law firms and corporations. XDD helps clients optimize their eDiscovery matters by orchestrating pristine communication between people, processes, technology and data. "
target:
QUiVX
QUiVX is an agile eDiscovery company providing advanced eDiscovery, review and consulting services to law firms and corporations. QUiVX services span the entire EDRM including; eDiscovery, forensics, review, analytics, hosting, consulting, trial preparation and paper discovery services.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
share
watch
bookmark
-
press release
closed 12/5/2018 via GlobeNewswire
Xact Data Discovery, acquired Esquify
synopsis: Xact Data Discovery (XDD), a leading international provider of eDiscovery, data management and managed review services for law firms and corporations, acquired Esquify, a cutting-edge software company that provides powerful AI automation workforce management solutions for legal review.
buyer parent:
JLL Partners
buyer: Xact Data Discovery
buyer: Xact Data Discovery
Xact Data Discovery (XDD) is a leading international provider of eDiscovery, data management and managed review services for law firms and corporations. XDD helps clients optimize their eDiscovery matters by orchestrating pristine communication between people, processes, technology and data. "
target:
Esquify
Esquify is a cutting-edge software company that provides powerful AI automation workforce management solutions for legal review. They are based in Chicago, IL.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
share
watch
bookmark
-
press release
closed 6/5/2018 via Company Press Release
JLL Partners, Water Street Healthcare Partners, acquired Triplefin
synopsis: Water Street Healthcare Partners, a strategic investor focused exclusively on the health care industry, and JLL Partners, a leading middle-market private equity firm, announced that they acquired Triplefin, an industry leader in patient support for more than 30 years.
buyer:
JLL Partners
buyer: Water Street Healthcare Partners
target: Triplefin
buyer: Water Street Healthcare Partners
Water Street is a strategic investor focused exclusively on health care. The firm has a strong record of building market-leading companies across key growth sectors in health care. JLL Partners is a leading middle-market private equity firm. "
target parent:
H.D. Smith
target: Triplefin
A market leader in patient support for more than 30 years, Triplefin delivers comprehensive hub services that improve patient access and adherence, including its patent-pending Rx365® suite of digital solutions.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
share
watch
bookmark
-
press release
closed 1/3/2018 via GlobeNewswire
JLL Partners, acquired Xact Data Discovery
synopsis: Xact Data Discovery (XDD), a leading international provider of eDiscovery, data management and managed review services for law firms and corporations, announced that it has been acquired by JLL Partners, a middle market private equity firm based in New York.
buyer:
JLL Partners
JLL Partners is a leading middle-market private equity firm with a 29-year track record of building and transforming businesses through its financial and operational expertise. Since its founding in 1988, JLL Partners has committed approximately $5 billion across seven funds. "
target:
Xact Data Discovery
Xact Data Discovery is a leading international provider of eDiscovery, data management and managed review services for law firms and corporations. XDD helps clients optimize their eDiscovery matters by orchestrating pristine communication between people, processes, technology and data.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
share
watch
bookmark
-
press release
closed 9/21/2015 via PR Newswire
BioClinica, Inc., acquired Synowledge
synopsis: BioClinica, Inc., a specialty clinical trials services and technology provider, announced that it has acquired Synowledge to expand into the drug safety and regulatory business process outsourcing market. Synowledge specializes in pharmacovigilance, regulatory affairs and information technology services to support biopharmaceutical companies.
buyer parent:
JLL Partners
buyer: BioClinica, Inc.
buyer: BioClinica, Inc.
BioClinica is a specialty clinical trials services provider that improves the development of new medical therapies by delivering expertise and technologies that enhance clinical research data and analytics, worldwide. "
target:
Synowledge
Synowledge is a specialized drug safety, regulatory affairs and IT services provider that assists and enables small, medium and large life sciences organizations to satisfy their global regulatory requirements.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
share
watch
bookmark
-
press release
closed 6/16/2014 via PR Newswire
BioClinica, Inc., acquired Blueprint Clinical
synopsis: BioClinica®, Inc., a leading provider of eClinical Solutions for the Pharmaceutical Industry, has announced the acquisition of Blueprint Clinical, a fast-growing company offering ground-breaking technology and extensive expertise to drive successful Risk-Based Monitoring (RBM) strategies for clinical trials.
buyer parent:
JLL Partners
buyer: BioClinica, Inc.
buyer: BioClinica, Inc.
BioClinica, Inc. is a leading global provider of integrated clinical trial management technologies including eClinical solutions for clinical trial supply management, forecasting and optimization, electronic data capture, randomization, and clinical trial management. "
target:
Blueprint Clinical
Blueprint Clinical, Inc. creates Software-as-a-Service tools that help improve monitoring of clinical trials. Their first product, Blueprint Clinical Compass™, ultimately allows risk based monitoring implementation thereby improving quality and efficiency of clinical trials.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
share
watch
bookmark
-
press release
announced 2/11/2013 via BusinessWire
JLL Partners, will acquire BioClinica, Inc.
synopsis: BioClinica®, Inc., a leading global provider of clinical trial management solutions and JLL Partners, Inc. announced that BC Acquisition Corp., which is a wholly-owned subsidiary of BioCore Holdings, Inc., each of which is an affiliate of JLL, has commenced a tender offer for all outstanding shares of BioClinica.
buyer:
JLL Partners
JLL Partners is a leading New York-based private equity investment firm with approximately $4 billion of capital under management. JLL Partners’ investment philosophy is to partner with outstanding management teams and invest in companies that they can continue to grow into market leaders. "
target:
BioClinica, Inc.
BioClinica, Inc. is a leading global provider of integrated, technology-enhanced clinical trial management solutions. BioClinica solutions maximize efficiency and manageability throughout all phases of the clinical trial process.
price ($mm)[EV]
$114 [$105]
rev ($mm)
$79
EBITDA ($mm)
$10
EV / rev
1.4x
EV / EBITDA
10.5x
share
watch
bookmark
-
press release
closed 6/22/2010 via Company Press Release
JLL Partners, acquired Ross Learning LLC
synopsis: Huron Capital announced today that it has sold its portfolio company, Ross Education. Based in St. Clair, Michigan, Ross Education operates a group of 17 postsecondary schools that offer career-oriented training in allied health fields.
buyer:
JLL Partners
target: Ross Learning LLC
Founded in 1988, JLL Partners is among the leading private equity investment firms in the country. Since inception, they have managed a series of private equity funds aggregating approximately $4 billion in committed capital. "
target parent:
Huron Capital Partners LLC
target: Ross Learning LLC
Ross Education LLC is the owner of Ross Medical Education Center. Ross has offered short-term vocational and career training programs for over 30 years. The Company operates a group of 17 postsecondary schools that offer career-oriented training in allied health fields.
price ($mm)
$232
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
share
watch
bookmark
-
press release
closed 12/17/2009 via BNC Analysis
Education Affiliates LLC, acquired MedVance Institute
synopsis: MedVance Institute announced Education Affiliates Inc. has acquired MedVance from Generation Partners and other shareholders. MedVance is a national leader in medical and allied health-related career training.
buyer parent:
JLL Partners
buyer: Education Affiliates LLC
target: MedVance Institute
buyer: Education Affiliates LLC
Education Affiliates Inc. is a leading post-secondary education company with a strong focus on allied health programs. EA has become one of the most prominent privately held school groups in the industry and currently operates a network of 40 campuses concentrated in 13 states in the eastern US. "
target parent:
Generation Partners
target: MedVance Institute
Headquartered in West Palm Beach, FL, MedVance provides Associate, Diploma and Certificate programs to recent high school graduates and adult students seeking education and training for positions in allied health.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
share
watch
bookmark
-
press release
Pages:
- buyer to watch list
- seller to watch list
Like THREAD Research
read more
Pages:
read more
read more
Pages:
read more
Geography
Matching Companies
Ticker: SYPT
Scrypt, Inc.
year
2009
rev ($mm)
$0.27
EBITDA ($mm)
($0.85)
EBIT ($mm)
($0.91)
Net Income ($mm)
Employees
7
drill down
watch
Ticker: OTCPK:LFER
Life on Earth, Inc.
year
2021
rev ($mm)
$0.03
EBITDA ($mm)
($0.64)
EBIT ($mm)
($0.96)
Net Income ($mm)
Employees
9
drill down
watch
Ticker: TSXV:MSD
Moseda Technologies, Inc.
year
2015
rev ($mm)
$0.02
EBITDA ($mm)
($1.86)
EBIT ($mm)
($1.86)
Net Income ($mm)
Employees
drill down
watch
Ticker: OM:RTC
Rethinking Care AB
year
2016
rev ($mm)
EBITDA ($mm)
EBIT ($mm)
Net Income ($mm)
Employees
drill down
watch
Ticker: OB:NORDH
Nordhealth AS
year
2021
rev ($mm)
$22.23
EBITDA ($mm)
($0.24)
EBIT ($mm)
($4.88)
Net Income ($mm)
Employees
300
drill down
watch
Ticker: DB:COP
CompuGroup Medical AG
year
2021
rev ($mm)
$1,158.07
EBITDA ($mm)
$194.47
EBIT ($mm)
$120.69
Net Income ($mm)
$74.78
Employees
8079
drill down
watch
Ticker: TRHC
Tabula Rasa Healthcare
year
2022
rev ($mm)
$339.59
EBITDA ($mm)
($27.37)
EBIT ($mm)
($76.52)
Net Income ($mm)
Employees
drill down
watch
Ticker: AIM:EMIS
EMIS Group PLC
year
2021
rev ($mm)
$221.66
EBITDA ($mm)
$54.10
EBIT ($mm)
$47.15
Net Income ($mm)
$38.31
Employees
1515
drill down
watch
Ticker: EVH
Evolent Health
year
2016
rev ($mm)
$212.24
EBITDA ($mm)
($39.30)
EBIT ($mm)
($52.25)
Net Income ($mm)
Employees
946
drill down
watch
Ticker: MTBC
Medical Transcription Billing, Corp.
year
2019
rev ($mm)
$65.19
EBITDA ($mm)
$1.78
EBIT ($mm)
($1.62)
Net Income ($mm)
Employees
2400
drill down
watch
Ticker: TSXV:THNK
Think Research
year
2021
rev ($mm)
$18.63
EBITDA ($mm)
($21.80)
EBIT ($mm)
($22.10)
Net Income ($mm)
Employees
189
drill down
watch
Ticker: K:HLYK
HealthLynked
year
2020
rev ($mm)
$4.84
EBITDA ($mm)
($2.77)
EBIT ($mm)
($2.87)
Net Income ($mm)
Employees
37
drill down
watch
Ticker: TSXV:BIO
AioCare
year
2015
rev ($mm)
$0.38
EBITDA ($mm)
($3.04)
EBIT ($mm)
($3.43)
Net Income ($mm)
$1.21
Employees
16
drill down
watch
Ticker: OTCPK:IGMB.D
Clinigence, LLC.
year
2018
rev ($mm)
$1.37
EBITDA ($mm)
($0.84)
EBIT ($mm)
($0.84)
Net Income ($mm)
Employees
0
drill down
watch
Ticker: TSXV:PHA
Premier Health of America Inc.
year
2020
rev ($mm)
$24.62
EBITDA ($mm)
$2.53
EBIT ($mm)
$2.36
Net Income ($mm)
$0.49
Employees
0
drill down
watch
Ticker: PRSC
ModivCare Inc.
year
2021
rev ($mm)
$1,454.99
EBITDA ($mm)
$190.61
EBIT ($mm)
$155.98
Net Income ($mm)
$91.58
Employees
17500
drill down
watch
Ticker: DFM:AMANAT
Amanat Holdings PJSC
year
2019
rev ($mm)
$38.69
EBITDA ($mm)
($2.11)
EBIT ($mm)
($6.34)
Net Income ($mm)
$16.34
Employees
0
drill down
watch
Ticker: AIM:NSCI
NetScientific
year
2018
rev ($mm)
$0.45
EBITDA ($mm)
($10.78)
EBIT ($mm)
($11.09)
Net Income ($mm)
Employees
drill down
watch
Ticker: SEHK:575
Regent Pacific Group Limited
year
2020
rev ($mm)
EBITDA ($mm)
($5.71)
EBIT ($mm)
($33.93)
Net Income ($mm)
Employees
19
drill down
watch
Ticker: NYSE:OHI
Omega Healthcare Investors, Inc.
year
2020
rev ($mm)
$892.38
EBITDA ($mm)
$770.19
EBIT ($mm)
$454.45
Net Income ($mm)
$159.33
Employees
0
drill down
watch
Ticker: OB:CARA
Carasent
year
2021
rev ($mm)
$12.97
EBITDA ($mm)
$3.21
EBIT ($mm)
$1.99
Net Income ($mm)
Employees
51
drill down
watch
Ticker: CNSX:AUSA
Australis Capital Inc.
year
2019
rev ($mm)
$0.19
EBITDA ($mm)
($7.49)
EBIT ($mm)
($7.51)
Net Income ($mm)
$3.87
Employees
0
drill down
watch
Ticker: CSE:GHG
Global Hemp Group Inc.
year
2014
rev ($mm)
EBITDA ($mm)
EBIT ($mm)
($1.92)
Net Income ($mm)
Employees
drill down
watch